Generic Melleretten
Common uses: Melleretten (Thioridazine) is used to treat schizophrenia and symptoms such as hallucinations, delusions, and hostility. Melleretten (Thioridazine) may also be used to treat other conditions as determined by your doctor. Click for more Melleretten details.
What is Generic Melleretten?
Generic Melleretten, like all generics, is the name given to the
prescription Thioridazine medication manufactured by any company other than the
original inventor of Melleretten. The only true difference between brand name Melleretten
and generic Melleretten is that generic Melleretten is always less expensive.
Also known as: Aldazine, Mallorol, Meleril, Mellaril, Melleril, Melzine, Ridazine, Thioridazinum, Tioridazina, Thioridazine (generic name).
Generic Melleretten made by Teva and Thioridazin produced by Neuraxpharm are at Goldpharma Medication | Strength | Quantity | Price | Goldpharma | Melleril Retard | 27.3 mg | 20 tablets | $29.97 | Order | Melleril Retard | 27.3 mg | 50 tablets | $41.62 | Order | Melleril Retard | 27.3 mg | 100 tablets | $60.26 | Order | Thioridazin | 22.76 mg | 20 tablets | $22.23 | Order | Thioridazin | 22.76 mg | 50 tablets | $24.87 | Order | Thioridazin | 22.76 mg | 100 tablets | $28.95 | Order | Thioridazin | 45.5 mg | 20 tablets | $23.68 | Order | Thioridazin | 45.5 mg | 50 tablets | $28.20 | Order | Thioridazin | 45.5 mg | 100 tablets | $35.11 | Order | Thioridazin | 91 mg | 20 tablets | $26.11 | Order | Thioridazin | 91 mg | 50 tablets | $33.81 | Order | Thioridazin | 91 mg | 100 tablets | $45.58 | Order | Thioridazin | 182 mg | 20 tablets | $30.37 | Order | Thioridazin | 182 mg | 50 tablets | $43.41 | Order | Thioridazin | 182 mg | 100 tablets | $63.42 | Order |
Buy Generic Melleretten - No Prior Prescription Needed*
How To Buy Generic Melleretten Online
Buy discount generic Melleretten (Thioridazine) online by clicking on one of the low
prices shown. You'll be sent to our secure shopping cart where you can safely
complete your transaction.
Melleretten - Health Bulletin
Drug Approved for Advanced Kidney CancerFRIDAY, Jan. 27 (HealthDay News) -- Inlyta (axitinib) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma in people who haven't responded to another drug. Renal cell carcinoma is a form of kidney cancer that begins in tissue that lines the kidney's small tubes. Inlyta blocks proteins that help fuel tumor growth in this area, the FDA said in a news release. Read entire article...
Please verify your local import regulations; the ability for a pharmacy to
offer a medication without a prescription does not negate any local requirement
you may have.
NOTICE: By using this site, you agree to verify and comply with your
country's rules and regulations should you undertake to purchase from any of
the listed pharmacies.
|